Helical Fusion Achieves Milestone Toward Commercial Fusion Energy, Advancing to Integrated Demonstration Device
27.10.2025 04:00:00 CET | Business Wire | Press Release
Helical Fusion Co., Ltd., a world-leading developer of the Helical Stellarator, has completed a critical performance test of a high-temperature superconducting (HTS) coil—a core component of commercial fusion reactors. The company has now commenced manufacturing and construction of its integrated demonstration device, Helix HARUKA.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251026597002/en/
Helical Fusion members celebrating the successful HTS test with an “HTS Graduation!” sign and graduation caps
Watch the key points of this release in a 2-minute video: https://youtu.be/UhgQHfKtvow
Helical Fusion is the only company in the world building upon expertise in the Helical Stellarator approach, accumulated for more than 60 years at national institutes and national universities, which has been proven to possess the optimal characteristics for commercial power generation. As the sole inheritor of this knowledge from the National Institute for Fusion Science (NIFS), Helical Fusion is driving the Helix Program to realize the world’s first commercially viable fusion power plant using the Helical Stellarator.
Under the Helix Program, the company aims to complete performance tests of its two key technologies—HTS magnets and the integrated blanket/divertor system—by the end of the 2020s. By the 2030s, Helical Fusion plans to achieve full system integration through Helix HARUKA and begin steady-state power generation with its fusion pilot plant, Helix KANATA.
About the Performance Test
Significance
This milestone marks the world's first successful demonstration of an HTS coil constructed with a fully-functional large-scale conductor:
- The coil is based on a conductor cable designed for commercial fusion power plants' scale use 1
- The test replicated the magnetic environment inside a fusion device 2, including both self-generated and external magnetic fields
- Successfully conducted a current test under superconducting conditions
Using NIFS’s unique large-diameter, high-field testing facility, the conductor achieved stable superconducting current flow at 40 kA under a 7-tesla external magnetic field at 15 K (-258°C).
This result establishes Helical Fusion as one of the world’s leading contenders in the race toward commercial fusion energy and meets the technical threshold required to advance to the integrated demonstration device, Helix HARUKA.
Strong Collaboration with the National Laboratory and the Government
Since its founding in 2021, Helical Fusion has worked closely with NIFS through multiple joint research initiatives. In March 2024, a dedicated joint research team and lab space were established at NIFS to accelerate the development of HTS magnets and blanket/divertor systems - a model of Japan’s public-private partnership in fusion innovation.
The company’s progress is supported by Japan’s SBIR Phase 3 program, the first national grant scheme dedicated to fusion energy under the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The establishment of this program was strongly initiated by Ms. Sanae Takaichi, the current Prime Minister of Japan, during her tenure as Minister for the Cabinet Office, where she championed the inclusion of fusion energy as a national strategic priority. Helical Fusion received the program’s largest amount, JPY 2 billion (≒USD 13 million).
Importance of HTS Magnet Development
Fusion reactors require magnetic fields strong enough to confine plasma exceeding 100 million degrees Celsius. For commercial plants, these fields must be generated efficiently and compactly — a challenge that makes HTS technology indispensable.
While many companies produce HTS materials, only a few possess the capability to design and engineer full-scale superconducting systems for real reactor environments. Helical Fusion’s success demonstrates its technical leadership in this domain.
About the Helix Program
The Helix Program targets the launch of the world’s first commercially viable fusion power plant in the 2030s through its Fusion Pilot Plant, Helix KANATA. The program defines three essential requirements for commercially viable fusion power:
- Steady-state operation: 24/7/365 stable performance
- Net electricity output: generating more energy than it consumes
- Maintainability: regular, efficient component maintenance
Out of more than 50 fusion development projects worldwide—spanning tokamak and laser-based approaches—the Helical Stellarator is uniquely capable of meeting all three criteria with existing technologies. The Helix Program aims to be the world’s first initiative to realize all of these requirements by the 2030s.
Powered by a strong partnership with NIFS and supported by Japan's world-class manufacturing industry, Helical Fusion is committed to leading the global fusion energy sector—a market expected to reach trillions of dollars in scale in the coming decades.
Comment from Co-Founder, CEO Takaya Taguchi
This achievement is undoubtedly a remarkable laboratory milestone born from Japan’s strong collaboration between industry, government, and academia.
Yet, more importantly, it marks a global turning point — a moment when everyone pursuing or believing in commercial fusion must recognize Helical Fusion as one of the most promising contenders for realization.
I am immensely proud of our joint team with the National Institute for Fusion Science (NIFS) — the giant of fusion research from which our company originated — and deeply grateful to our Japanese manufacturing partners whose craftsmanship made this success possible.
As we move forward to the next stage, we invite the world to watch closely and share in the excitement of what comes next.
Comment from Co-Founder, CTO Junichi Miyazawa
The development of high-temperature superconducting (HTS) magnets marks a powerful shift from laboratory research to real-world implementation.
Over years of dedicated work, the global fusion community has advanced material and magnet technologies that did not even exist when I began our research — technologies that now give us strong confidence in achieving commercial fusion power.
This successful test is the culmination of many years of development and close collaboration with partners across academia and industry. We will channel our deepest gratitude into the continued progress of Helix HARUKA and Helix KANATA.
About Helical Fusion Co., Ltd.
Helical Fusion is a Japan-based startup developing the world’s first commercially viable net power fusion plant, leveraging the expertise of the Helical Stellarator and inheriting more than 60 years of national fusion research.
Helical Fusion has raised JPY 5.2 billion (≈USD 34 million) to date and targets commercial operation in the 2030s under its “Helix Program”.
| ___________________________________ |
1 This coil is made using advanced high-temperature superconducting (HTS) technology, and it was constructed without electrical insulation. Among all HTS coil technologies, this marks the world’s first successful test of uninsulated a large-scale HTS conductor-based coil. |
| 2 “the magnetic environment inside a fusion device” refers to a setting in which external magnetic fields—separate from those generated by the coil itself—are present, creating complex electromagnetic interactions between multiple currents through the magnetic field. In future fusion power plants, such environments are expected to include intense radiation, neutron flux, and even stronger magnetic fields. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20251026597002/en/
Contacts
Media contact: contact@helicalfusion.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Estée Lauder Companies Announces BEAUTY&YOU India 2026 Winners and Marks Five Years of Advancing Indian Beauty Entrepreneurship15.10.2026 17:58:00 CEST | Press Release
The Estée Lauder Companies, in partnership with Nykaa and Startup India, an initiative of the Department for Promotion of Industry and Internal Trade (DPIIT) within India’s Ministry of Commerce and Industry, announced the winners of BEAUTY&YOU India 2026, the country’s leading beauty entrepreneurship program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015612324/en/ (L to R) BEAUTY&YOU India 2026 Winners Ajaykumar Mehta, Shriya Rambhia, and Dheer Rambhia, Directors, Goyam Green Tech (BREAKTHROUGH), Nirja Bhatt, Founder & CEO, Laani (GROW), Khatija Shabana, CEO, and Syed Mohammad Fouzan, Director, Boldpurity (IMAGINE), Rinzing Choden Bhutia, Founder, Agapi Sikkim (Visionary Women’s Award), and Pankti Sheth, Founder & Creative Director, De Icebreaker Creative Studio (DESIGN). For five years, BEAUTY&YOU India has discovered, supported, and accelerated India’s next generation of beauty entrepreneurs. Since launching in 202
BioLab Holdings Launches EmeraNova™ to Advance the Future of Tissue Restoration15.10.2026 17:00:00 CEST | Press Release
BioLab Holdings announced today a new, larger mission with the launch of EmeraNova™, a new corporate identity that reflects a broader ambition to advance tissue restoration across specialties, healing phases, and care settings. The launch marks the company’s efforts to build a global platform focused on identifying promising technologies and accelerating their path into clinical practice. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015721831/en/ EmeraNova seeks partners around the world to bring promising technologies to market quickly and equip clinicians with advanced, effective solutions. EmeraNova represents a vision to pursue emerging (Emer) and new (Nova) technologies by building an expanding toolbox of tissue restoration solutions, world-class support, and ways to bring together expert voices and clinical insights that will help shape what comes next. The company’s roots in chronic wound care will inform its fut
Body of Waves , a New Artwork Only at teamLab Planets TOKYO, Unveiled15.10.2026 17:00:00 CEST | Press Release
teamLab Planets TOKYO (hereinafter referred to as “teamLab Planets”) has unveiled Body of Waves, a new artwork in which visitors enter a soft sculpture with their entire bodies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014474897/en/ teamLab, Body of Waves, 2026, from the series Soft Black Hole - Your Body Becomes a Space that Influences Another Body, 2016-© teamLab *Shot in real space. No AI or CGI. In addition, Existence in the Flow Creates Vortices—where vortices are created behind people as they climb against the flow—and Waterfall of Ephemeral Crystals—where shining particles cascade down to create a waterfall of light particles—have also evolved, further expanding the experience at teamLab Planets. New Artwork Body of Waves As you walk, your feet sink. This force is transmitted to the large, soft and flexible sculpture spreading across the floor, causing the sculpture to physically deform. The force generated b
CTIBIOTECH™ Announces Strategic Partnership and MOU With Beijing Vital River to Advance Preclinical Biomedical Innovation in China15.10.2026 16:59:00 CEST | Press Release
CTIBIOTECH™, a pioneering Contract Research, Development, and Manufacturing Organization (CRDMO) and global leader in 3D bioprinting of human tissues, today announces the signing of a Memorandum of Understanding (MOU) and strategic partnership with Beijing Vital River, a Charles River company and provider of research models and associated preclinical services in China. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014604195/en/ CTIBIOTECH signs strategic partnership with Beijing Vital River, a Charles River Laboratories company for commercialization of human tissue bioassays and New Approach Methodologies (NAMs) in Popular Republic of China The agreement was signed in Shanghai during the Shanghai – Auvergne-Rhône-Alpes Economic Dialogue, organized by the Nouvel Institut Franco-Chinois (NIFC), as part of the official Auvergne-Rhône-Alpes Region delegation to China. This alliance is designed to bring CTIBIOTECH™'s unique p
Navan Unveils New Ways to Book, Expense, and Travel at Navigate Europe 202615.10.2026 16:30:00 CEST | Press Release
Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, unveiled a new set of capabilities and product updates at Navigate Europe, its flagship customer conference. The updates bring Navan into more workplace tools, expand card issuing to new currencies, and simplify guest reimbursement, all while giving businesses greater visibility and control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015250476/en/ “Business never stands still. Our customers are constantly expanding and expecting more value, which is why we continue to innovate and elevate every part of the employee experience,” said Michael Riegel, Chief Customer Officer at Navan. “We’ve spent years building the global technology infrastructure and expertise to make travel and expense work better. These new capabilities will support more users in more ways than ever before, all from one connected platform that moves as fast as they do.”
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom